<?xml version="1.0" encoding="ISO-8859-1"?>
<entity-relation-data lastUpdate="2023-03-27 16:06:20" record="811" source="Espacenet">
	<entities>
		<entity ref="Patent811" type="Patent">
			<semanticIdentifier>brcris::50d4777890ae292dd2735cc1550ecb68</semanticIdentifier>
			<semanticIdentifier>docdb::BR9902912A</semanticIdentifier>
			<semanticIdentifier>epodoc::BR9902912</semanticIdentifier>
			<semanticIdentifier>docdb::BR9902912A</semanticIdentifier>
			<semanticIdentifier>epodoc::BR19999902912</semanticIdentifier>
			<semanticIdentifier>original::9902912-0</semanticIdentifier>
			<field name="urlEspacenet" value="https://worldwide.espacenet.com/patent/search?q=9902912"/>
			<field name="identifier.lattes" value="5748745713292417"/>
			<field name="identifier.espacenet" value="9902912"/>
			<field name="kindCode" value="A"/>
			<field name="title.espacenet" value="Uso de microesferas de quitosana no encapsulamento de substancias e preparação de fitoterápicos."/>
			<field name="title.lattes" value="Uso de microesferas de Quitosana no Encapsulamento de Substâncias e preparação de Fitoterápicos"/>
			<field name="depositDate" value="1999-07-21"/>
			<field name="publicationDate" value="2001-03-06"/>
			<field name="countryCode" value="BR"/>
			<field name="inventor" value="AFRANIO ARAGAO CRAVEIRO"/>
			<field name="applicant" value="AFRANIO ARAGAO CRAVEIRO"/>
			<field name="classification.ipc">
				<field name="sequence" value="1"/>
				<field name="text" value="A61K9/52AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="K"/>
				<field name="group" value="9"/>
				<field name="subgroup" value="52AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="2"/>
				<field name="text" value="A61K9/62AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="K"/>
				<field name="group" value="9"/>
				<field name="subgroup" value="62AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="3"/>
				<field name="text" value="A61K31/722AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="K"/>
				<field name="group" value="31"/>
				<field name="subgroup" value="722AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="4"/>
				<field name="text" value="A61P31/04AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="P"/>
				<field name="group" value="31"/>
				<field name="subgroup" value="04AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="5"/>
				<field name="text" value="A61P31/10AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="P"/>
				<field name="group" value="31"/>
				<field name="subgroup" value="10AI"/>
			</field>
			<field name="abstract.espacenet" value="USO DE MICROESFERAS DE QUITOSANA NO ENCAPSULAMENTO DE SUBSTANCIAS E PREPARAçãO DE FITOTERáPICOS&lt;D&gt;. A presente invenção refere-se a preparação de microesferas utilizando quitosana e seus derivados como agentes de microencapsulamento de substâncias farmacológicamente ativas e extratos vegetais para uso na preparação de fitoterápicos e em liberação controlada de substâncias. As propriedades deste biopolímero permitem a formação de micro ou nanoesferas conjugadas com compostos ou extratos vegetais permitindo a preparação de fitoterápicos em nova formulação evitando vários problemas associados com as formulações tradicionais e incorporando as vantagens associadas ao uso da quitosana que incluem propriedades antibacteriana e antifungica e até mesmo aumento na eficiência da absorção no caso de produtos cosméticos para a pele ou cabelo. Outra grande vantagem do uso de microesferas se deve ao fato destas permitirem a liberação controlada ao mesmo tempo em aumentam a eficiência e a absorção do compostos ativos que estão incorporados no interior das mesmas."/>
			<field name="originatesFrom" value="4072865"/>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="9902912"/>
				<field name="kind" value="A"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BR9902912"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="9902912"/>
				<field name="kind" value="A"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BR19999902912"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="original"/>
				<field name="country" value=""/>
				<field name="number" value="9902912-0"/>
				<field name="kind" value=""/>
			</field>
		</entity>
		<entity ref="Person576" type="Person">
			<semanticIdentifier>lattes::5748745713292417</semanticIdentifier>
			<field name="identifier.lattes" value="5748745713292417"/>
			<field name="name" value="Afrânio Aragao Craveiro"/>
		</entity>
	</entities>
	<relations>
		<relation fromEntityRef="Patent811" toEntityRef="Person576" type="Inventor"/>
		<relation fromEntityRef="Patent811" toEntityRef="Person576" type="Depositor"/>
	</relations>
</entity-relation-data>
